First 10 runs free
    Intelligence Feed event · Equity · 2026-11-12

    GE HealthCare lifts 2026 organic revenue guidance to 4% with $23.7B equipment backlog

    Question

    GE HealthCare lifts 2026 organic revenue guidance to 4% with $23.7B equipment backlog

    Direct answer

    GE HealthCare increased its full-year organic revenue guidance to 4% after posting 6.2% organic growth in the third quarter. The performance was supported by strong imaging and medical hardware demand. The total equipment backlog expanded 12% year over year to $23.7 billion. Pharmaceutical Diagnostics continues to deliver recurring revenue that cushions medical device margin volatility.

    Original publisher
    Market Ontology
    Evidence through
    2026-11-12
    Published
    2026-11-12
    Revision
    1 · 2026-11-12

    Cite as: Market Ontology, “GE HealthCare lifts 2026 organic revenue guidance to 4% with $23.7B equipment backlog”, revision 1, evidence through 2026-11-12. https://marketontology.com/market-events/2026-11-12/ge-healthcare-lifts-2026-organic-revenue-guidance-to-4-with-23-7b-equipment-back-10a507

    EQUITY
    GE HealthCare lifts 2026 organic revenue guidance to 4% with $23.7B equipment backlog
    GE HealthCare increased its full-year organic revenue guidance to 4% after posting 6.2% organic growth in the third quarter. The performance was supported by strong imaging and medical hardware demand. The total equipment backlog expanded 12% year over year to $23.7 billion. Pharmaceutical Diagnostics continues to deliver recurring revenue that cushions medical device margin volatility.
    GEHC
    Impact
    68
    NOV 12
    SIG
    90%
    GEHC
    GE HealthCare lifts 2026 organic revenue guidance to 4% with $23.7B equipment backlog
    GE HealthCare increased its full-year organic revenue guidance to 4% after posting 6.2% organic growth in the third quarter. The performance was supported by strong imaging and medical hardware demand. The total equipment backlog expanded 12% year over year to $23.7 billion. Pharmaceutical Diagnostics continues to deliver recurring revenue that cushions medical device margin volatility.
    → A 12% expansion in equipment backlog to $23.7 billion improves revenue visibility and drives GEHC forward revenue guidance to 4% organic growth.
    Impact
    GE HealthCare increased its full-year organic revenue guidance to 4% after posting 6.2% organic growth in the third quarter. The performance was supported by strong imaging and medical hardware demand. The total equipment backlog expanded 12% year over year to $23.7 billion. Pharmaceutical Diagnostics continues to deliver recurring revenue that cushions medical device margin volatility.
    Affected
    GEHC
    Transmission
    A 12% expansion in equipment backlog to $23.7 billion improves revenue visibility and drives GEHC forward revenue guidance to 4% organic growth.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    GEHCexpanded order book flow-through to forward medical equipment billingsUp1-4wGE HealthCare raised organic guidance to 4% and reported $23.7 billion backlog.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    Find trades for this development

    Screen tradable expressions of this catalyst against your horizon and constraints. Nothing is submitted without your review.

    First 10 runs free

    First 10 runs free

    See today's live cards

    Public pages are published 24 hours after the product shows them. The product shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open live cards